Body Mass Index (BMI) at the timeof treatment for penile cancer has noeffect on patients’ prognosis, accordingto an online report in UrologiaInternationalis

Rosa S. Djajadiningrat, MD, and colleaguesat The Netherlands CancerInstitute in Amsterdam, evaluated433 penile cancer patients whohad a mean BMI of 26.8 kg/m2. 

Theresearchers found no significant associationbetween BMI and AmericanJoint Committee on Cancer stage atdiagnosis and observed no significantdifferences in disease-specific survivalamong difference BMI classes.The researchers cited a previousstudy suggesting that obese penilecancer patients in the United Statestend to present at later stages of thedisease than non-obese patients. 

Continue Reading